Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis

Area of Science:

• Immunogenetics
• Pediatric Dermatology
• Allergy Research

Background:

• Atopic dermatitis (AD) is a prevalent childhood skin disorder with significant physical and psychological impacts.
• While environmental factors play a role, AD has a strong genetic basis, potentially linked to other allergic conditions like asthma.

Purpose of the Study:

• To investigate the association between polymorphisms in the cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene and early-onset childhood atopic dermatitis (AD).
• CTLA4 is a key regulator of T-cell activity and has been previously linked to asthma and autoimmune diseases.

Main Methods:

• A family-based cohort of 112 children diagnosed with AD within the first three years of life was studied in Western Sydney, Australia.
• The transmission disequilibrium test was employed to assess associations of the +49 and CT60 polymorphisms in the CTLA4 gene.

Main Results:

• The +49(A) allele showed a significant association with AD (P = 0.037).
• The CT60(A) allele displayed borderline significance (P = 0.055).
• A significant association was found for the combined +49(A)/CT60(A) haplotype (P = 0.002), indicating a shared genetic risk factor.

Conclusions:

• Polymorphisms in the CTLA4 gene are associated with early-onset infant atopic dermatitis.
• The findings suggest that the +49(A)/CT60(A) CTLA4 haplotype is a common genetic risk factor for both atopic dermatitis and asthma.